CAS NO: | 1258595-14-0 |
包装 | 价格(元) |
1mg | 电议 |
5mg | 电议 |
10mg | 电议 |
50mg | 电议 |
100mg | 电议 |
200mg | 电议 |
生物活性 | LHC-165 is aTLR7agonist. LHC-165 has potential to used in study of solid tumors[1][2]. | ||||||||||||||||
IC50& Target[1] |
| ||||||||||||||||
Clinical Trial | |||||||||||||||||
分子量 | 603.55 | ||||||||||||||||
性状 | Solid | ||||||||||||||||
Formula | C29H32F2N3O7P | ||||||||||||||||
CAS 号 | 1258595-14-0 | ||||||||||||||||
运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||||||||||
储存方式 | -20°C, stored under nitrogen *In solvent : -80°C, 6 months; -20°C, 1 month (stored under nitrogen) | ||||||||||||||||
溶解性数据 | In Vitro: 1M NaOH : 50 mg/mL(82.84 mM;ultrasonic and adjust pH to 12 with NaOH) 配制储备液
* 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 |